Prognostic PET/CT Model in Non Small Cell Lung Cancer
Completed
- Conditions
- Non Small Cell Lung Cancer
- Registration Number
- NCT03199599
- Lead Sponsor
- Poitiers University Hospital
- Brief Summary
Prospective validation of a prognostic model based on advanced PET/CT image analysis in non small cell lung cancer
- Detailed Description
Validation on a prospective cohort of patient of a predictive model for survival based on image derived parameters
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- non small cell lung cancer
- initial fluorodeoxygluoces (FDG) PET/CT before treatment
exclusion criteria:
- none
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method validation of a multiparametric PET/CT prognostic model 18 months overall survival rate
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie PET/CT-based prognostic models in NSCLC?
How does advanced PET/CT analysis compare to standard imaging for NSCLC survival prediction?
Which biomarkers correlate with improved outcomes in NCT03199599 NSCLC prognostic model?
What adverse events are associated with PET/CT imaging in NSCLC patient monitoring?
Are there combination therapies leveraging PET/CT insights for NSCLC treatment optimization?
Trial Locations
- Locations (1)
Chu Poitiers
🇫🇷Poitiers, France
Chu Poitiers🇫🇷Poitiers, France